Is MDGL up or down today?
MDGL is down 1.28% today, last at 534.16. This stock moved -1.28% versus the prior close.
MDGL · MDGL
MDGL (MDGL) is trading at 534.16, down 1.28% on the session. MDGL carries a 14-day RSI of 52, and trades above its 50-day average. Over the past month it is up 4.73%.
Leading the coverage: “Madrigal Pharmaceuticals to Participate in the 2026 Cantor Global Healthcare Conference” (Yahoo Finance, 6d ago). MDGL is -0.84% since story.
MDGL trades on a trailing P/E of 33.3 and is running 5.67% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
MDGL is down 1.28% today, last at 534.16. This stock moved -1.28% versus the prior close.
Leading the coverage: “Madrigal Pharmaceuticals to Participate in the 2026 Cantor Global Healthcare Conference” (Yahoo Finance, 6d ago). MDGL is -0.84% since story. Dominant story: Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A 27% Upside Potential Amid Biotech Innovation - DirectorsTalk Interviews (1 source, neutral) RSI is 52 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (124 days) · Drag or scroll left for earlier dates
Madrigal Pharmaceuticals (MDGL) Stock Analysis: A 25% Upside Potential In Biotech Innovation - DirectorsTalk Interviews
Madrigal Pharmaceuticals to Participate in the 2026 Cantor Global Healthcare Conference
(MDGL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A 27% Upside Potential Amid Biotech Innovation - DirectorsTalk Interviews
MDGL Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Slip - Net Profit Margin - dars.gov.et